C&C International Prices ERP Friction, Not the Buyback Clock

Summary: At 13:27 KST on 2026-05-27, 352480.KQ traded at KRW 21,400, down 5.73% intraday and sitting only 0.9% above the KRW 21,200 reference price the board used in its new buyback-trust filing a day earlier. That is the setup. The market is still trading C&C International through a margin scare. The board just placed a live bid almost exactly where the stock now sits. If the first-quarter squeeze was mostly ERP friction, new-capacity under-absorption, and mix inefficiency rather than lasting demand damage, the stock is being priced too close to the bad print and too far from any normal margin path. [1][2][3][4][5]

Opportunity Ranking

Rank	Idea	Discovery Lane	Why It May Be Best Now	Evidence Freshness	Catalyst Window	Asymmetry	Main Reason to Reject
1	C&C International prices ERP friction, not the buyback clock	Korea / KOSDAQ / mid-cap / cosmetics ODM / margin scare versus capital return	The stock traded at KRW 21,400 at 13:27 KST on 2026-05-27, almost identical to the board's KRW 21,200 buyback reference. The company just approved a KRW 5.0 billion buyback trust for 235,849 shares, or about 1.73% of shares outstanding, while first-quarter revenue still grew 7.4% year over year even as operating profit fell 46.6% on execution friction. [1][2][3]	High	High. Buyback trust starts 2026-05-27 and runs through 2026-11-30. [2]	High enough. The downside sits near the recent low, while the market is still treating a fixable execution problem as a structural earnings reset.	Selected.
2	Mgame prices a slow tape, not the August burn	Korea / KOSDAQ / small-mid cap / gaming / low multiple and capital return	Mgame was KRW 4,955 at 13:00 KST on 2026-05-22. It announced a KRW 2.0 billion buyback from 2026-05-15 to 2026-08-14, targeting 411,100 shares or about 2.14% of shares, with a plan to cancel all acquired stock. The name also screens cheaply, with a roughly KRW 87.8 billion market cap and a trailing cash-return profile. [6][7]	Medium	Medium-high. The buyback runs until 2026-08-14. [6]	Moderate. Cheap and orderly, but the rerating case is more mechanical and the catalyst is smaller than the Korea finalist.	The mispricing is real but less surprising. It is a cleaner value-and-buyback lane, not the sharpest disagreement today.
3	OVAL prices the new plan, but not much more	Japan / TSE Standard / small-mid cap / compliant Japan screen under JPY 800	OVAL closed at JPY 796 on 2026-05-25 after trading JPY 799 on 2026-05-22. It announced a buyback for 2.2 million shares, or 9.82% of issued share capital, for JPY 800 million, and pays a JPY 10 dividend on 2026-06-29. [8][9]	Medium	Medium-high. Buyback runs until 2026-08-17 and dividend pays 2026-06-29. [9]	Moderate. The capital-return package is real, but the rerating is already underway and the freshest price evidence is older than the Korea finalists.	Strongest compliant Japan candidate, but it lost on evidence freshness and near-term disagreement intensity.

Selected opportunity: C&C International (352480.KQ)

Why this one now: It is the best mix of live price evidence, a dated and active shareholder-return program, and a market that still seems anchored to a weak quarter rather than to the temporary sources of that weakness.

What should surprise the reader: The board just told you where it is willing to buy stock, and that price is almost the current tape. Yet the stock is still trading only 7.3% above its 52-week low even though revenue is still growing and the company is explicitly spending to repair the operating system that hurt margins. [1][2][3][4]

Japan And Korea Scope Audit

This run was explicitly scoped by the user to Japan and Korea low/mid caps, so I did not widen the screen to the U.S. or Europe.

Korean search used: 자기주식취득 신탁계약, 주가안정 및 주주가치 제고, ERP 생산 차질, 중소형주, 실적 가시성 악화, 소각 예정.
Japanese search used: 自己株式取得, 自己株式消却, 東証スタンダード, 700円台, 低PBR, 株主還元.
Strongest compliant Japan candidate: OVAL, last verified at JPY 796 on 2026-05-25, which satisfied the Japan preference for a local small-mid-cap name priced at or below JPY 800 when screened. [8]
Why the Korea finalist still won: C&C had the freshest tape, the clearest live board bid, and the sharper disagreement between current price and current catalyst.

The Setup

C&C International is a Korean color-cosmetics ODM. Its own corporate materials describe a business exporting across Asia, Japan, Europe, and North America while building a new AI-enabled operating stack and a new Cheongju smart-factory footprint. [5]

The first-quarter print was weak enough to reset sentiment.

On 2026-05-11, the company reported KRW 70.837 billion of first-quarter revenue and KRW 2.967 billion of operating profit. Revenue rose 7.4% year over year. Operating profit fell 46.6%. [3]

The market's instinctive read was simple: growth is fine, but the operating machine is losing its shape.

That read is not fabricated. Newsway's post-results reporting tied the pressure to heavier production-equipment investment, ERP buildout, and utilization lag. It noted that annual production capacity had expanded to roughly 349 million units while actual production ran nearer 193 million, leaving fixed-cost absorption behind capacity growth. [4]

But the same evidence also argues that the damage is operational and transitional, not necessarily structural. Seoul Economic Daily's April reporting described the new AI Labs initiative, a SAP-based ERP rollout, and a next-year Cheongju smart-factory plan as part of a mid-term efficiency rebuild rather than a distress response. [5]

Then, on 2026-05-26, the board approved a new buyback trust.

The Mispricing

The market appears to be pricing C&C International as if the first-quarter margin damage is the durable state of the business. The alternative view is narrower and more useful: the company is paying the cost of changing its production and control system, and the board has started buying stock almost exactly where the tape now sits.

Confirmed facts

At 13:27 KST on 2026-05-27, Hankyung's live market page showed the stock at KRW 21,400, down KRW 1,300 or 5.73% intraday. [1]
The same live page showed a KRW 291.7 billion market cap, 13,629,901 listed shares, a 52-week range of KRW 19,940 to KRW 48,900, trailing EPS of KRW 1,329, and BPS of KRW 26,036. That implies a live price-to-book of about 0.82x at the checked price. [1]
On 2026-05-26, the board approved a KRW 5.0 billion buyback trust with KB Securities, running from 2026-05-27 through 2026-11-30. The filing used KRW 21,200 as the reference share price and indicated 235,849 shares, or about 1.73% of outstanding shares. The filing also said shares acquired through the trust are intended for cancellation or employee compensation, with any cancellation subject to a later board resolution. [2]
On 2026-05-11, first-quarter revenue rose 7.4% year over year to KRW 70.837 billion, while operating profit fell 46.6% to KRW 2.967 billion and net profit rose 25.2% to KRW 5.083 billion. [3]

Inference

The tape is still acting as if weak margins are the whole story. The board is acting as if the stock is cheap enough to buy at almost the same level.

Reasonable but unverified judgment

The market is likely over-annualizing a quarter distorted by production-mix inefficiency, ERP transition costs, and under-absorbed new capacity. That does not guarantee a fast margin snapback. It does mean the current price already embeds a heavy penalty for execution mistakes that management is explicitly trying to fix. [4][5]

Price

Market Level	Value	Timestamp / Source	Why It Matters
Live price	KRW 21,400	2026-05-27 13:27 KST, Hankyung live stock page [1]	Current entry reference
Intraday move	-5.73%	Same check [1]	The stock is still being sold despite the fresh buyback trust
Previous close	KRW 22,700	Same check [1]	Shows the current drop is material, not rounding noise
Intraday range	KRW 21,350 to KRW 23,300	Same check [1]	Confirms live volatility and where the tape found support
Market cap	KRW 291.7 billion	Same check [1]	Mid-cap lane confirmed
Shares outstanding	13,629,901	Same check [1]	Base for buyback math
52-week range	KRW 19,940 to KRW 48,900	Same check [1]	Current price is only 7.3% above the low and 56.2% below the high
Live P/B	0.82x	Calculated from KRW 21,400 price and KRW 26,036 BPS on same page [1]	Market values the stock below book even after the return program starts
Board's buyback reference price	KRW 21,200	Buyback filing, board decision dated 2026-05-26 [2]	Current tape is only 0.9% above the board's own bid reference
Buyback size	KRW 5.0 billion	Same filing [2]	About 1.71% of live market cap
First-quarter revenue / operating profit	KRW 70.837 billion / KRW 2.967 billion	2026-05-11 filing [3]	Confirms sales still grew while margins compressed

Positioning

I do not have reliable live short-interest, borrow-cost, or options-open-interest data for this name. I will not invent them.

The usable positioning evidence is simpler:

The board just committed a fresh, finite, cash-backed bid at almost the current market price. [2]
The stock is hovering close to its 52-week low despite that decision. [1]
The dominant sell-side counterargument is now explicit: visibility is worse, product mix has become less efficient, and ERP rollout slowed operations. [4]

That is enough to say the market is leaning hard into the execution scare. It is not enough to claim a crowded short.

Catalyst

Catalyst 1: The buyback trust is live now. It runs from 2026-05-27 to 2026-11-30. This is a real demand window, not a presentation slide. [2]

Catalyst 2: Any later cancellation decision would change the market's reading of intent. The filing explicitly preserves cancellation as an intended use of repurchased shares. [2]

Catalyst 3: Margin recovery does not need heroic revenue growth. First-quarter revenue still rose 7.4% year over year. If ERP friction and under-absorption ease, even a modest operating-margin recovery can matter materially from this price level. [3][4][5]

Catalyst 4: The business mix is still expanding geographically. Newsway reported last year's overseas sales reached KRW 141.0 billion, up 26%, with North America particularly strong and the Shanghai unit turning profitable. [4]

The surprise is not that C&C is a growth company. The surprise would be that the stock can rerate without needing its old growth multiple back, simply by proving the operating machine is not broken.

Payoff Map

Facts: The stock is live at KRW 21,400, the board's buyback reference is KRW 21,200, book value per share is KRW 26,036, and the first-quarter margin collapse happened alongside continuing revenue growth. [1][2][3]

Inference: The market is pricing an execution problem as if it were a durable franchise impairment.

Speculation, clearly marked: If the next two quarters show even partial normalization in throughput and margin, the stock does not need a premium multiple to move materially. A return toward book value or a still-discounted growth multiple is enough.

Trade expression: The cleanest expression is long common stock. I rejected options because I did not verify a liquid listed-options chain, and the thesis is about an operational repair window rather than a one-day binary event.

Price Target And Probability Map

Scenario	Probability	Target / Level	Return / Payoff	Time Horizon	Conditions Required	Evidence Quality
Top Case	25%	KRW 29,500	+37.9%	3 to 6 months	Buyback progresses cleanly, margins recover from ERP and utilization drag, and the market rerates the stock toward a still-conservative multiple of repaired earnings power	Medium
Base Case	50%	KRW 25,500	+19.2%	2 to 5 months	The market stops pricing the first quarter as a lasting margin state and the stock drifts back toward book-adjacent valuation	Medium
Bottom Case	25%	KRW 18,500	-13.6%	1 to 4 months	The margin problem proves structural, utilization remains weak, and the buyback is treated as too small or too flexible to matter	Medium
Invalidation / Stop Condition	n/a	Below KRW 19,800 on a closing basis	n/a	Immediate on trigger	Fresh disclosures show another material margin reset, cancellation intent disappears, or revenue slows while margin stays pinned	Medium

Probability-weighted expected value: KRW 24,750, or about 15.7% above the checked price.

Current market price / level: KRW 21,400. [1]

Timestamp: 2026-05-27 13:27 KST. [1]

Primary instrument: C&C International common stock (352480.KQ).

Alternative expressions considered: Waiting for the next quarterly print, or waiting for a later cancellation decision after buyback accumulation starts. Both are cleaner, but both surrender part of the disagreement if the market moves first.

Confidence: Medium.

What Would Prove This Wrong

The thesis fails in four ways.

The market is right that the first-quarter margin damage is structural rather than transitional.
The company keeps adding capacity faster than it can fill it, so utilization remains a chronic drag. [4]
The buyback trust becomes economically irrelevant because execution is too slow or the shares are not ultimately canceled. [2]
Revenue growth itself rolls over, leaving no room for operating leverage to repair the story.

A closing break below KRW 19,800 on fresh negative evidence would invalidate the trade.

Risk Audit

Strongest counterargument: C&C is not cheap in the only metric that matters if earnings are resetting. At a live price of KRW 21,400, the market is not buying a distressed asset. It is buying a company whose trailing profitability already fell hard, whose ERP rollout disrupted production, whose multi-product, small-batch mix is inherently margin-noisy, and whose new-capacity spending may stay ahead of actual demand. The buyback is only 1.7% of market cap and may end up supporting compensation inventory as much as shareholder return. [1][2][4]

Most fragile assumption: That the ERP and utilization drag fade faster than the market expects.

What the market may already know: Quite a lot. The weak quarter is public, the buyback is public, and the operational-repair narrative is public. The edge is not hidden information. It is weighting current evidence differently.

What could make the trade lose money even if the thesis is directionally right: Time and sequencing. If operating repair is real but slow, the market can stay skeptical for longer than a tactical long wants.

Liquidity / execution risks: Moderate. This is a KOSDAQ mid-cap that traded 22,529 shares by 13:27 KST in the checked session. Use limit orders. [1]

Leverage risks: Poor fit. The setup is about re-rating and operational repair, not a high-convexity event where leverage is necessary.

Information reliability risks: The live price and basic market data came from Hankyung's embedded market state. The buyback and first-quarter results came from Korean disclosure reporting that reproduced filing terms. The operational-repair narrative relies on business reporting, not just raw filings. [1][2][3][4][5]

Invalidation trigger: Close below KRW 19,800 with fresh evidence that margins are not recovering or that shareholder-return intent weakens.

Publish / revise / reject recommendation: Publish. The disagreement is specific, current, and still priced close to the board's own buyback level.

Bottom Line

C&C International is not being priced like a business in repair. It is being priced like a business that already failed. That is too harsh. The first quarter was weak, but revenue still grew, book value still sits well above the tape, and the board just put a live bid almost exactly where the stock trades now. The clean trade is long common stock, with discipline around KRW 19,800.

Best Trade Strategy

Best trade: Long C&C International common stock (352480.KQ).

This is not an options-first setup.

Research Quality Scorecard

Criterion	Score	Evidence Note
Market disagreement	5	The disagreement is precise: the market is pricing a margin-reset story while the board is buying stock almost at the current tape and the company is still growing revenue. [1][2][3]
Evidence base	4	Live price and filing-derived facts are fresh. The weaker point is that some operational interpretation comes from business reporting rather than a full raw-filing packet in this run. [1][2][3][4][5]
Positioning and flows	3	Mechanical corporate demand is clear, but borrow, short-interest, and derivative positioning are not verified. [2]
Catalyst path	4	The buyback clock is observable and immediate, but the bigger rerating still depends on operating proof in later quarters. [2][3]
Payoff architecture	4	Upside does not require a heroic multiple, and downside can be tied to the recent low and a thesis-break condition.
Invalidation discipline	4	A close below KRW 19,800 plus continued margin deterioration would clearly break the thesis.
Differentiated insight	4	The non-obvious point is that the board's buyback reference and the live tape are nearly the same price, which frames the market-versus-management disagreement cleanly. [1][2]
Client value	4	Useful even without taking the trade because it shows how to separate a capacity-and-systems problem from a demand problem.

Total Score: 32 / 40

Verdict: Publish-ready Deep Dive Trade Note

Sources

AI Illustration Prompt

Create a realistic, high-value, high-end editorial cover image for The Mispricing Desk about C&C International in late May 2026. The central tension is operational friction versus an active board-level buyback. Stage the scene inside a premium Korean cosmetics ODM factory control room at dusk. In the foreground, place a stainless-steel worktable with neatly arranged lip-tint tubes, production tickets, and two marked folders: one stamped Q1 margin scare and another stamped KRW 5bn buyback trust. Show the buyback folder lit by a narrow beam of white task light while the margin scare folder sits under a harsher amber industrial glow. In the mid-ground, include partially automated filling lines and ERP dashboard screens showing slowed throughput, then a second monitor showing the live stock line near KRW 21,400 and the board's KRW 21,200 reference price almost overlapping. The composition should feel forensic, expensive, and slightly tense, like a Bloomberg Markets or Economist feature illustration shot by an elite commercial photographer. Palette: graphite, brushed aluminum, ivory packaging white, muted rose, and cold blue screen light. No generic upward charts, no rockets, no meme-trader visuals. Include a subtle but clear text treatment reading The Mispricing Desk.